"Antigen Presentation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989)
| Descriptor ID |
D017951
|
| MeSH Number(s) |
G12.119 G12.450.050.400.070
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigen Presentation".
Below are MeSH descriptors whose meaning is more specific than "Antigen Presentation".
This graph shows the total number of publications written about "Antigen Presentation" by people in this website by year, and whether "Antigen Presentation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 0 | 2 |
| 1997 | 4 | 0 | 4 |
| 1998 | 3 | 2 | 5 |
| 1999 | 5 | 3 | 8 |
| 2000 | 0 | 3 | 3 |
| 2001 | 4 | 6 | 10 |
| 2002 | 3 | 4 | 7 |
| 2003 | 5 | 3 | 8 |
| 2004 | 0 | 3 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 5 | 5 |
| 2008 | 2 | 5 | 7 |
| 2009 | 2 | 5 | 7 |
| 2010 | 3 | 3 | 6 |
| 2011 | 0 | 1 | 1 |
| 2012 | 4 | 4 | 8 |
| 2013 | 5 | 10 | 15 |
| 2014 | 3 | 6 | 9 |
| 2015 | 0 | 4 | 4 |
| 2016 | 4 | 2 | 6 |
| 2017 | 0 | 4 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 6 | 7 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 2 | 3 |
| 2023 | 2 | 2 | 4 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigen Presentation" by people in Profiles.
-
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation. Commun Biol. 2024 Feb 24; 7(1):228.
-
Restoring tolerance with antigen delivery. Science. 2024 01 05; 383(6678):30-32.
-
Epithelial IFN? signalling and compartmentalized antigen presentation orchestrate gut immunity. Nature. 2023 Nov; 623(7989):1044-1052.
-
Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity. Biomaterials. 2023 11; 302:122334.
-
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T-cell responses. Mucosal Immunol. 2024 Jun; 17(3):416-430.
-
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation. J Thorac Oncol. 2023 09; 18(9):1222-1232.
-
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Sci Rep. 2022 12 29; 12(1):22539.
-
Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses. Cell Rep. 2022 11 01; 41(5):111563.
-
Positive and negative selection shape the human naive B cell repertoire. J Clin Invest. 2022 01 18; 132(2).
-
Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68. J Immunol. 2021 12 15; 207(12):2944-2951.